.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Colorcon
Julphar
Medtronic
Fish and Richardson
Mallinckrodt
Chinese Patent Office
Queensland Health
Baxter

Generated: December 16, 2017

DrugPatentWatch Database Preview

Ipratropium bromide - Generic Drug Details

« Back to Dashboard

What are the generic sources for ipratropium bromide and what is the scope of ipratropium bromide freedom to operate?

Ipratropium bromide
is the generic ingredient in three branded drugs marketed by Boehringer Ingelheim, Actavis Mid Atlantic, Apotex Inc, Aurobindo Pharma Ltd, Bausch And Lomb Inc, Landela Pharm, Mylan Speciality Lp, Nephron, Pharmascience Inc, Ritedose Corp, Roxane, Sun Pharma Global, Teva Pharms Usa, Watson Labs, Bausch And Lomb, and West-ward Pharms Int, and is included in twenty-six NDAs. There are three patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Ipratropium bromide has fifty-eight patent family members in thirty-seven countries.

There are seven drug master file entries for ipratropium bromide. Twenty-two suppliers are listed for this compound.

Pharmacology for ipratropium bromide

Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists

Medical Subject Heading (MeSH) Categories for ipratropium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Aurobindo Pharma LtdIPRATROPIUM BROMIDEipratropium bromideSOLUTION;INHALATION206543-001Oct 27, 2016ANRXNoNo► Subscribe► Subscribe► Subscribe
Bausch And Lomb IncIPRATROPIUM BROMIDEipratropium bromideSOLUTION;INHALATION075835-001Oct 15, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Apotex IncIPRATROPIUM BROMIDEipratropium bromideSOLUTION;INHALATION075441-001Mar 28, 2001DISCNNoNo► Subscribe► Subscribe► Subscribe
Actavis Mid AtlanticIPRATROPIUM BROMIDEipratropium bromideSOLUTION;INHALATION075111-001Apr 22, 1999DISCNNoNo► Subscribe► Subscribe► Subscribe
Landela PharmIPRATROPIUM BROMIDEipratropium bromideSOLUTION;INHALATION077072-001Jul 19, 2005ANRXNoNo► Subscribe► Subscribe► Subscribe
Boehringer IngelheimATROVENTipratropium bromideSOLUTION;INHALATION020228-001Sep 29, 1993DISCNYesNo► Subscribe► Subscribe► Subscribe
West-ward Pharms IntIPRATROPIUM BROMIDEipratropium bromideSPRAY, METERED;NASAL076664-001Nov 5, 2003ABRXNoNo► Subscribe► Subscribe► Subscribe
Boehringer IngelheimATROVENT HFAipratropium bromideAEROSOL, METERED;INHALATION021527-001Nov 27, 2004RXYesYes► Subscribe► SubscribeY► Subscribe
Mylan Speciality LpIPRATROPIUM BROMIDEipratropium bromideSOLUTION;INHALATION074755-001Jan 10, 1997DISCNNoNo► Subscribe► Subscribe► Subscribe
Boehringer IngelheimATROVENT HFAipratropium bromideAEROSOL, METERED;INHALATION021527-001Nov 27, 2004RXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: ipratropium bromide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Boehringer IngelheimATROVENTipratropium bromideSPRAY, METERED;NASAL020394-001Oct 20, 1995► Subscribe► Subscribe
Boehringer IngelheimATROVENTipratropium bromideAEROSOL, METERED;INHALATION019085-001Dec 29, 1986► Subscribe► Subscribe
Boehringer IngelheimATROVENT HFAipratropium bromideAEROSOL, METERED;INHALATION021527-001Nov 27, 2004► Subscribe► Subscribe
Boehringer IngelheimATROVENT HFAipratropium bromideAEROSOL, METERED;INHALATION021527-001Nov 27, 2004► Subscribe► Subscribe
Boehringer IngelheimATROVENT HFAipratropium bromideAEROSOL, METERED;INHALATION021527-001Nov 27, 2004► Subscribe► Subscribe
Boehringer IngelheimATROVENT HFAipratropium bromideAEROSOL, METERED;INHALATION021527-001Nov 27, 2004► Subscribe► Subscribe
Boehringer IngelheimATROVENTipratropium bromideSPRAY, METERED;NASAL020393-001Oct 20, 1995► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Ingredient: ipratropium bromide

Country Document Number Estimated Expiration
New Zealand516317► Subscribe
Norway325134► Subscribe
Peru01072001► Subscribe
Uruguay26165► Subscribe
Poland352052► Subscribe
China1106999► Subscribe
Norway20015718► Subscribe
Poland205866► Subscribe
HungaryE025069► Subscribe
Serbia49749► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
Julphar
Chinese Patent Office
Healthtrust
Merck
Novartis
QuintilesIMS
Johnson and Johnson
UBS
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot